According to Bloomberg Ratings, the fifteen research firms following HealthEquity, Inc. (NASDAQ: HQY) have collectively assigned the company a “Moderate Buy” rating as their consensus recommendation. The research firms gave this rating to reflect their collective opinion regarding the company’s potential for growth. Only one of the research analysts recommended keeping the stock in one’s portfolio, while seven others recommended buying the stock. A recommendation to sell the stock was made by one of the research analysts. The average price target for one year that brokerage firms have provided that have issued reports on the company in the previous year is $81.23.
Several equity analysts have published recent reports on the company’s shares, and these reports are based on the most recent findings that these analysts have obtained. In a report on December 7th, Wells Fargo & Company downgraded their “overweight” rating on HealthEquity shares and decreased their price objective on the stock from $104.00 to $101.00. Both of these changes resulted from a decrease in their price target on the stock. The “hold” rating that StockNews.com had previously assigned to its recommendation on shares of HealthEquity has been replaced with a “sell” rating, as stated in a research note published on Friday, January 6th. Robert W. Baird increased their target price on HealthEquity stock to $75.00 in a research note published on Monday, December 12th. Guggenheim upgraded HealthEquity from a “hold” rating to a “buy” rating and increased their target price on the stock from $89.00 to $94.00 in a research report published on Wednesday, December 7th. The target price that Jefferies Financial Group has set for HealthEquity shares has increased from $800.00 to $90.00, as stated in a research note that was published on November 2nd. This was the company’s final action, but by no means its the least important one.
The company’s director, Gayle Furgurson Wellborn, sold 5,237 shares of the company’s stock on December 14th. Other recent shifts include the following: Because the price of each share was determined to be $62.00 on average, the transaction’s total value was $324,694.00. As a result of the transaction, the director now has direct ownership of 12,023 shares of the company, which have a combined value of $745,426. If you follow this link, you will be taken to the filing submitted to the Securities and Exchange Commission, where the transaction was discussed, and it will take you there immediately. 2.80% of the company’s stock is owned by individuals considered to be “corporate insiders.”
During the second quarter, Private Trust Co. NA established a new health equity position with an investment of approximately $28,000. Many hedge funds and institutional investors have been buying and selling HQY shares. During the second quarter, Assetmark Inc. increased the amount of HealthEquity stock held by 387.1 percent from the previous quarter. Assetmark Inc. now has 755 shares of the company’s stock, with a combined value of $46,000. These shares were acquired due to the company’s purchase of 600 shares during the relevant period. Wipfli Financial Advisors LLC invested approximately $69,000 during the third quarter of the year to further strengthen its position in health equity. Benjamin F. Edwards & Company, Inc. increased the percentage of HealthEquity stock that it held by 31.3% during the third quarter. Benjamin F. Edwards & Company, Inc. now has 1,049 shares of the company’s stock after purchasing an additional 250 shares during the most recent period. Based on the stock’s current price, Benjamin F. Edwards & Company, Inc.’s holdings are estimated to be worth $70,000. During the second quarter, Eagle Bay Advisors LLC increased the percentage of HealthEquity shares it owned by 137.8 percent. This was done so as not to be outdone by its competitors. After purchasing an additional 642 shares during the relevant period, Eagle Bay Advisors LLC now has 1,108 shares of the company’s stock, equivalent to $68,000. These shares were acquired during the period in question. Most of the company’s stock is currently held by various institutional investors, including hedge funds, to the tune of 99.54 percent.
NASDAQ: HQY was first available for trading on Friday, with an opening price of $57.41. The debt-to-equity ratio was calculated to be 0.48, the current ratio was determined to be 3.01, and the quick ratio was also calculated to be 3.01. The price of one share of HealthEquity fluctuated between $48.42 and $79.20 over the twelve months leading up to the most recent one. The price-to-earnings ratio for this company is -80.01; the price-to-growth ratio for this company is 3.08; and the beta value for this company is 0.80. The company currently has a market capitalization of $4.86 billion. The stock’s price has reached $61.51 on its moving average over the past 50 days, while it has reached $64.65 on its moving average over the past 200 days.
On Tuesday, December 6th, HealthEquity (NASDAQ: HQY) released its most recent quarterly earnings report for the investing public. The quarterly earnings per share came in at $0.21, which was $0.01 higher than the estimate by analysts, which was $0.20. Analysts made the consensus estimate. Even though HealthEquity’s net margin was negative by 7.07 percent, the company still generated a positive return on equity of 2.82 percent. Market analysts projected that the company would bring in between $206.58 million and $216.09 million in revenue during the quarter. This range of revenue was anticipated for the company. According to the forecasts of equity market researchers, HealthEquity will bring in $0.74 in profits per share for the current fiscal year.
Consumers and businesses in the United States can utilize technology-enabled service platforms thanks to HealthEquity, Inc. People can pay their medical bills, receive personalized benefits and clinical information, assess treatment options and costs, gain wellness incentives, increase their savings, and make investment decisions using platforms hosted in the cloud. Clinical information, treatment options, cost evaluation, wellness incentives, increased savings, and decision-making regarding investment opportunities are all included. In addition to starting health savings accounts, this should be done.
